• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Development of Next Generation Probiotics for Cardiometabolic Diseases.

作者信息

Khan Muhammed Tanweer, Bäckhed Fredrik

机构信息

Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden 41345.

Biogaia AB, 112 27 Stockholm, Sweden.

出版信息

Phenomics. 2025 Mar 21;5(1):18-22. doi: 10.1007/s43657-025-00230-z. eCollection 2025 Feb.

DOI:10.1007/s43657-025-00230-z
PMID:40313602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12040764/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c324/12040764/0c613c6635ff/43657_2025_230_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c324/12040764/0c613c6635ff/43657_2025_230_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c324/12040764/0c613c6635ff/43657_2025_230_Fig1_HTML.jpg

相似文献

1
Development of Next Generation Probiotics for Cardiometabolic Diseases.用于心脏代谢疾病的下一代益生菌的研发。
Phenomics. 2025 Mar 21;5(1):18-22. doi: 10.1007/s43657-025-00230-z. eCollection 2025 Feb.
2
Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases.肠道微生物群调节作为心血管代谢疾病的一种新型治疗策略
Foods. 2022 Aug 25;11(17):2575. doi: 10.3390/foods11172575.
3
Chronic consumption of probiotics, oats, and apples has differential effects on postprandial bile acid profile and cardiometabolic disease risk markers compared with an isocaloric control (cornflakes): a randomized trial.与等热量对照（玉米片）相比，慢性摄入益生菌、燕麦和苹果对餐后胆汁酸谱和心血管代谢疾病风险标志物有不同的影响：一项随机试验。
Am J Clin Nutr. 2023 Feb;117(2):252-265. doi: 10.1016/j.ajcnut.2022.10.013. Epub 2022 Dec 19.
4
Modulation of Gut Microbiota for Health by Current and Next-Generation Probiotics.通过现有和下一代益生菌调节肠道微生物群以促进健康。
Nutrients. 2019 Aug 15;11(8):1921. doi: 10.3390/nu11081921.
5
Gut microbiota and probiotics intervention: A potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease?肠道微生物群和益生菌干预：管理心血管代谢疾病和慢性肾脏病的潜在治疗靶点？
Pharmacol Res. 2018 Apr;130:152-163. doi: 10.1016/j.phrs.2018.01.020. Epub 2018 Feb 14.
6
Research trends of next generation probiotics.下一代益生菌的研究趋势
Food Sci Biotechnol. 2024 Jun 24;33(9):2111-2121. doi: 10.1007/s10068-024-01626-9. eCollection 2024 Jul.
7
Gut microbiota and probiotic intervention as a promising therapeutic for pregnant women with cardiometabolic disorders: Present and future directions.肠道微生物群和益生菌干预作为一种有前途的治疗妊娠合并心血管代谢疾病的方法：现状和未来方向。
Pharmacol Res. 2019 Jul;145:104252. doi: 10.1016/j.phrs.2019.104252. Epub 2019 May 2.
8
Targeting the Gut Microbiome to Treat Cardiometabolic Disease.靶向肠道微生物组治疗心血管代谢疾病。
Curr Atheroscler Rep. 2024 Feb;26(2):25-34. doi: 10.1007/s11883-023-01183-2. Epub 2024 Jan 5.
9
Next generation probiotics in disease amelioration.改善疾病的新一代益生菌。
J Food Drug Anal. 2019 Jul;27(3):615-622. doi: 10.1016/j.jfda.2018.12.011. Epub 2019 Feb 2.
10
The triple interactions between gut microbiota, mycobiota and host immunity.肠道微生物群、真菌群和宿主免疫之间的三重相互作用。
Crit Rev Food Sci Nutr. 2023 Nov;63(33):11604-11624. doi: 10.1080/10408398.2022.2094888. Epub 2022 Jul 1.

本文引用的文献

1
The keystone gut species boosts gut microbial biomass and voluntary physical activity in mice.关键肠道菌物种可促进肠道微生物生物量和小鼠的自愿体力活动。
mBio. 2024 Feb 14;15(2):e0283623. doi: 10.1128/mbio.02836-23. Epub 2023 Dec 22.
2
Synergy and oxygen adaptation for development of next-generation probiotics.协同作用和氧气适应与下一代益生菌的开发。
Nature. 2023 Aug;620(7973):381-385. doi: 10.1038/s41586-023-06378-w. Epub 2023 Aug 2.
3
treatment promotes weight gain in Bangladeshi infants with severe acute malnutrition.治疗可促进孟加拉国严重急性营养不良婴儿的体重增加。
Sci Transl Med. 2022 Apr 13;14(640):eabk1107. doi: 10.1126/scitranslmed.abk1107.
4
Selection of a novel strain of Christensenella minuta as a future biotherapy for Crohn's disease.选择新型微小真杆菌菌株作为克罗恩病的未来生物疗法。
Sci Rep. 2022 Apr 11;12(1):6017. doi: 10.1038/s41598-022-10015-3.
5
Calorie restriction improves metabolic state independently of gut microbiome composition: a randomized dietary intervention trial.热量限制可改善代谢状态，与肠道微生物组组成无关：一项随机饮食干预试验。
Genome Med. 2022 Mar 14;14(1):30. doi: 10.1186/s13073-022-01030-0.
6
SER-109, an Oral Microbiome Therapy for Recurrent Infection.SER-109，一种用于复发性感染的口腔微生物组疗法。
N Engl J Med. 2022 Jan 20;386(3):220-229. doi: 10.1056/NEJMoa2106516.
7
Pivotal Roles for pH, Lactate, and Lactate-Utilizing Bacteria in the Stability of a Human Colonic Microbial Ecosystem.pH、乳酸及利用乳酸的细菌在人类结肠微生物生态系统稳定性中的关键作用
mSystems. 2020 Sep 8;5(5):e00645-20. doi: 10.1128/mSystems.00645-20.
8
A unified catalog of 204,938 reference genomes from the human gut microbiome.人类肠道微生物组 204938 个参考基因组的统一目录。
Nat Biotechnol. 2021 Jan;39(1):105-114. doi: 10.1038/s41587-020-0603-3. Epub 2020 Jul 20.
9
Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation.2型糖尿病患者餐后血糖控制的改善：一项新型益生菌制剂的多中心、双盲、随机安慰剂对照试验。
BMJ Open Diabetes Res Care. 2020 Jul;8(1). doi: 10.1136/bmjdrc-2020-001319.
10
The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study.基于人群的横断面研究：糖尿病前期和糖尿病中的肠道微生物群。
Cell Metab. 2020 Sep 1;32(3):379-390.e3. doi: 10.1016/j.cmet.2020.06.011. Epub 2020 Jul 10.